Analyst firms · Barclays · INMD
Barclays INMD price target and rating history
InMode Ltd. (INMD) · Health Care
Barclays rates InMode Ltd. (INMD) Overweight with a $44 price target, as of its latest action on Dec 21, 2022. It has published 3 rating actions on INMD since July 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Overweight
- Price target
- $44
- Median target, all firms
- Too few
- Actions on INMD
- 3
Barclays price target on INMD
Every Barclays rating on INMD
- Dec 21, 2022
- Oct 13, 2021
- Jul 13, 2021
Questions about Barclays and INMD
- What is Barclays's price target for INMD?
- Barclays's latest stated price target for InMode Ltd. (INMD) is $44, from its action on Dec 21, 2022.
- What is Barclays's rating on INMD?
- Barclays rates INMD Overweight, a bullish rating, as of Dec 21, 2022.
- When did Barclays last change its view on INMD?
- On Dec 21, 2022, Barclays starts coverage at Overweight, price target $44.
More INMD rating histories
All Barclays ratingsINMD news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.